Skip to main content
. Author manuscript; available in PMC: 2014 Jul 3.
Published in final edited form as: Bone Marrow Transplant. 2009 Aug 10;45(3):429–436. doi: 10.1038/bmt.2009.189

Table 3b.

Characteristics of four patients tested for DSA who experienced graft failure

Patient nos. 1 2 3 4
Donor-specific anti-HLA antibodies Y Y Y N
Age 43 37 39 29
Gender F F F M
Diagnosis AML AML AML AML
% BM blasts at transplant 0 13 23 2
Donor Sib Sib Son Parent
Sex mismatch (Y/N) Y N Y N
No. of allele mismatched* 3 4 5 5
Alloreactive KIR-LM in HVG direction 0 0 0 0
CMV mismatch (R/D) R+/D− R+/D+ R+/D− R+/D +
ABO mismatch Major Minor Minor Minor
Cell type PB PB PB PB
No. of CD34+ cells infused (× 106/kg) 14.8 6.6 17.5 11.1
No. of pregnancies 0 3 2 NA
No. of PRBCs transfused before transplant 37 41 65 13

Abbreviations: ABO = blood group; D = donor; DSA = donor-specific anti-HLA antibodies; F = female; HVG = host-vs-graft; KIR-LM = killer Ig-like receptor-ligand mismatch; M = male; NA = not applicable; PB = peripheral blood; PRBCs = packed RBCs; R = recipient; Sib = sibling. Patients with antibodies were all females, two out of three multiparous, and all heavily transfused before transplant. *Number of allele mismatches were appreciated on the basis of HLA A, B, C, DRB1, DQB1 typing.